News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
303,877 Results
Type
Article (18166)
Company Profile (33)
Press Release (285678)
Section
Business (87569)
Career Advice (1056)
Deals (16249)
Drug Delivery (25)
Drug Development (45940)
Employer Resources (24)
FDA (7594)
Job Trends (6713)
News (156860)
Policy (12849)
Tag
Academia (771)
Allergies (27)
Alliances (16559)
Alzheimer's disease (483)
Approvals (7572)
Artificial intelligence (29)
Bankruptcy (136)
Best Places to Work (5295)
Breast cancer (46)
Cancer (426)
Career advice (903)
Cell therapy (84)
Clinical research (37210)
Collaboration (90)
Compensation (58)
COVID-19 (1151)
Data (497)
Diabetes (57)
Diagnostics (2158)
Earnings (50789)
Events (48479)
Executive appointments (57)
FDA (7772)
Funding (82)
Gene therapy (55)
GLP-1 (258)
Government (1558)
Healthcare (7401)
Infectious disease (1181)
Inflammatory bowel disease (44)
Interviews (247)
IPO (8940)
Job creations (1584)
Job search strategy (672)
Layoffs (129)
Legal (2532)
Lung cancer (79)
Manufacturing (50)
Medical device (5003)
Medtech (5003)
Mergers & acquisitions (7298)
Metabolic disorders (156)
Neuroscience (592)
NextGen Class of 2024 (2106)
Non-profit (1437)
Northern California (530)
Obesity (89)
Opinion (53)
Patents (35)
People (15549)
Phase I (11012)
Phase II (16981)
Phase III (12769)
Pipeline (135)
Postmarket research (1510)
Preclinical (3825)
Radiopharmaceuticals (95)
Rare diseases (75)
Real estate (2000)
Regulatory (9264)
Research institute (729)
Resumes & cover letters (183)
Southern California (451)
Startups (1111)
United States (4578)
Vaccines (252)
Weight loss (64)
Date
Last 7 days (280)
Last 30 days (1072)
Last 365 days (16602)
2024 (13416)
2023 (17988)
2022 (25401)
2021 (26223)
2020 (23892)
2019 (18331)
2018 (12984)
2017 (12136)
2016 (10752)
2015 (13598)
2014 (9626)
2013 (6925)
2012 (7688)
2011 (22245)
2010 (39350)
Location
Africa (273)
Arizona (54)
Asia (17956)
Australia (2781)
California (1103)
Canada (505)
China (101)
Colorado (38)
Connecticut (52)
Delaware (36)
Europe (42452)
Florida (123)
Georgia (53)
Illinois (108)
Indiana (86)
Japan (27)
Kansas (29)
Maine (29)
Maryland (183)
Massachusetts (838)
Michigan (47)
Minnesota (76)
New Hampshire (30)
New Jersey (351)
New York (394)
North Carolina (315)
Northern California (530)
Ohio (41)
Pennsylvania (308)
South America (458)
Southern California (451)
Texas (133)
Washington State (125)
303,877 Results for "12".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
October 3, 2024
·
1 min read
·
Angela Gabriel
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024
Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) today announced that the Company will be participating in the Emerging Growth Conference on June 12, 2024.
June 11, 2024
·
2 min read
Drug Development
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor
Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the first patient had been dosed in the Phase 1/2 trial of TSN1611 for the treatment of KRAS G12D mutant solid tumors in the United States.
May 24, 2024
·
2 min read
Deals
KALA BIO Announces $12,500,000 Private Placement
KALA BIO, Inc. today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors for the sale, in a private placement, of shares of its common stock and shares of its Series H Convertible Non-Redeemable Preferred Stock (the “Series H Preferred Stock”), for aggregate gross proceeds of approximately $12.5 million, before deducting offering expenses.
June 27, 2024
·
4 min read
SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will hold a fireside chat at the Virtual Emerging Growth Conference on Wednesday, June 12 at 12:35 p.m. Eastern time (9:35 a.m. Pacific time).
June 6, 2024
·
3 min read
Business
OmniAb to Report Third Quarter 2024 Financial Results on November 12
October 22, 2024
·
2 min read
BioMidwest
Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
Zomedica Corp. announced that Peter Donato, EVP and Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti Small Cap Conference, taking place on June 12-13, 2024.
June 10, 2024
·
1 min read
Drug Development
Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP)
Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP).
June 24, 2024
·
9 min read
Deals
Assembly Biosciences Announces $12.6 Million in Equity Financings
Assembly Biosciences, Inc. today announced that it has closed the issuance of shares of its common stock and warrants to Armistice Capital LLC (“Armistice Capital”), a healthcare-focused institutional investor, and Gilead Sciences, Inc. (“Gilead”), in separate equity financings that have resulted in aggregate gross proceeds to Assembly Bio of approximately $12.6 million, before deducting expenses.
June 17, 2024
·
5 min read
1 of 30,388
Next